These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18985860)

  • 1. Identification of IGFBP-6 as an effector of the tumor suppressor activity of SEMA3B.
    Koyama N; Zhang J; Huqun ; Miyazawa H; Tanaka T; Su X; Hagiwara K
    Oncogene; 2008 Nov; 27(51):6581-9. PubMed ID: 18985860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semaphorin 3B inhibits the phosphatidylinositol 3-kinase/Akt pathway through neuropilin-1 in lung and breast cancer cells.
    Castro-Rivera E; Ran S; Brekken RA; Minna JD
    Cancer Res; 2008 Oct; 68(20):8295-303. PubMed ID: 18922901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GATA3 targets semaphorin 3B in mammary epithelial cells to suppress breast cancer progression and metastasis.
    Shahi P; Wang CY; Chou J; Hagerling C; Gonzalez Velozo H; Ruderisch A; Yu Y; Lai MD; Werb Z
    Oncogene; 2017 Oct; 36(40):5567-5575. PubMed ID: 28581515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect.
    Castro-Rivera E; Ran S; Thorpe P; Minna JD
    Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11432-7. PubMed ID: 15273288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B.
    Tomizawa Y; Sekido Y; Kondo M; Gao B; Yokota J; Roche J; Drabkin H; Lerman MI; Gazdar AF; Minna JD
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13954-9. PubMed ID: 11717452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Semaphorin 3B (SEMA3B) in Various Grades of Endometrial Cancer.
    Dziobek K; Opławski M; Grabarek B; Zmarzły N; Januszyk P; Adwent I; Dąbruś D; Leśniak E; Kiełbasiński R; Kieszkowski P; Boroń D
    Med Sci Monit; 2019 Jun; 25():4569-4574. PubMed ID: 31217417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone and 1,25-dihydroxyvitamin D₃ inhibit endometrial cancer cell growth by upregulating semaphorin 3B and semaphorin 3F.
    Nguyen H; Ivanova VS; Kavandi L; Rodriguez GC; Maxwell GL; Syed V
    Mol Cancer Res; 2011 Nov; 9(11):1479-92. PubMed ID: 21933904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal regulation and distinct functions of semaphorin-3B and semaphorin-3F in ovarian cancer.
    Joseph D; Ho SM; Syed V
    Mol Cancer Ther; 2010 Feb; 9(2):499-509. PubMed ID: 20124444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semaphorin-3B is an angiogenesis inhibitor that is inactivated by furin-like pro-protein convertases.
    Varshavsky A; Kessler O; Abramovitch S; Kigel B; Zaffryar S; Akiri G; Neufeld G
    Cancer Res; 2008 Sep; 68(17):6922-31. PubMed ID: 18757406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A functional genomics approach for the identification of putative tumor suppressor genes: Dickkopf-1 as suppressor of HeLa cell transformation.
    Mikheev AM; Mikheeva SA; Liu B; Cohen P; Zarbl H
    Carcinogenesis; 2004 Jan; 25(1):47-59. PubMed ID: 14555616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment.
    Rolny C; Capparuccia L; Casazza A; Mazzone M; Vallario A; Cignetti A; Medico E; Carmeliet P; Comoglio PM; Tamagnone L
    J Exp Med; 2008 May; 205(5):1155-71. PubMed ID: 18458115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of SEMA3B methylation and expression patterns in gastric cancer tissue and cell lines.
    Chen R; Zhuge X; Huang Z; Lu D; Ye X; Chen C; Yu J; Lu G
    Oncol Rep; 2014 Mar; 31(3):1211-8. PubMed ID: 24402303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SEMA3B improves the survival of patients with esophageal squamous cell carcinoma by upregulating p53 and p21.
    Tang H; Wu Y; Liu M; Qin Y; Wang H; Wang L; Li S; Zhu H; He Z; Luo J; Wang H; Wang Q; Luo S
    Oncol Rep; 2016 Aug; 36(2):900-8. PubMed ID: 27349960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placental SEMA3B expression is not altered in severe early onset preeclampsia.
    Kaitu'u-Lino TJ; Hastie R; Cannon P; Binder NK; Lee S; Stock O; Hannan NJ; Tong S
    Placenta; 2014 Dec; 35(12):1102-5. PubMed ID: 25454475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alteration of SEMA3B gene expression levels in epithelial tumors].
    Pronina IV; Loginov VI; Prasolov VS; Klimov EA; Khodyrev DS; Kazubskaia TP; Gar'kavtseva RF; Sulimova GE; Braga EA
    Mol Biol (Mosk); 2009; 43(3):439-45. PubMed ID: 19548530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution analysis of 3p deletion in neuroblastoma and differential methylation of the SEMA3B tumor suppressor gene.
    Nair PN; McArdle L; Cornell J; Cohn SL; Stallings RL
    Cancer Genet Cytogenet; 2007 Apr; 174(2):100-10. PubMed ID: 17452250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGFBP-4 activates the Wnt/beta-catenin signaling pathway and induces M-CAM expression in human renal cell carcinoma.
    Ueno K; Hirata H; Majid S; Tabatabai ZL; Hinoda Y; Dahiya R
    Int J Cancer; 2011 Nov; 129(10):2360-9. PubMed ID: 21207373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer.
    Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Williams NN; Kaiser LR; Croce CM
    Cancer Res; 2003 Jun; 63(12):3352-5. PubMed ID: 12810670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SEMA3B-AS1-inhibited osteogenic differentiation of human mesenchymal stem cells revealed by quantitative proteomics analysis.
    Zhang C; Zhu Y; Liu Y; Zhang X; Yue Q; Li L; Chen Y; Lu S; Teng Z
    J Cell Physiol; 2019 Mar; 234(3):2491-2499. PubMed ID: 30317552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of candidate tumor-suppressor genes in 3p21.3 and investigation of the methylation of gene promoters in oral squamous cell carcinoma.
    Wang K; Ling T; Wu H; Zhang J
    Oncol Rep; 2013 Mar; 29(3):1175-82. PubMed ID: 23292452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.